FDA Brief

Warning letters Drugs

FDA warning letter to

New Earth Healing Essentials, LLC d/b/a 5D Full Disclosure

High riskIssued Feb 1, 2022Posted Feb 8, 2022Center for Drug Evaluation and Research | CDER

FDA warned 5D Full Disclosure that its colloidal silver eye drops, nasal spray and elixirs are unapproved new drugs, including for children and pets.

What happened

FDA reviewed the company’s website and Facebook page from November through December 2021 and found it took orders for seven colloidal silver, copper and gold products. The pages claimed the products treat or cure infections, cancer, arthritis and other diseases, and some were labeled for children and pets. FDA said the products are unapproved new drugs (not generally recognized as safe and effective and not FDA-approved) and that two are also unapproved new animal drugs.

What FDA found

  1. The seven products are unapproved new drugs because they are not generally recognized as safe and effective and have no FDA-approved application.

    FD&C Act sections 201(p), 505(a), 301(d); 21 U.S.C. 321(p), 355(a), 331(d)
  2. The company’s website and Facebook claims establish that the products are intended to treat or cure diseases, including infections, cancer and arthritis.

    FD&C Act section 201(g)(1); 21 U.S.C. 321(g)(1)
  3. Plasma Colloidal Silver Eyedrops and Copper Healing Roller are unapproved new animal drugs because they are intended for pets and have no approved animal drug application.

    FD&C Act sections 201(v), 512(a), 501(a)(5); 21 U.S.C. 321(v), 360b(a), 351(a)(5)

What FDA wants

FDA asks the company to write within 15 working days describing specific steps taken to correct the violations, how it will prevent recurrence, and copies of related documentation. If corrective actions cannot be completed in that time, the company must state why and when it will finish.

Who should pay attention

  • online platforms and retailers selling colloidal silver products
  • brands selling eye drops or nasal sprays with drug claims
  • pet product sellers making unproven drug claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk